Uncle Willie, have you read the FDA's reply to the petition that was filed at the White House?
http://www.e-cigarette-forum.com/forum/legislation-news/249012-reply-fda.html
Have you read the IOM's report on the scientific studies that should be completed before any product can claim to be reduced-risk when compared to smoking?
http://www.e-cigarette-forum.com/fo...ied-risk-tobacco-products-released-today.html
Reasonable regulations and standards are one thing, but "clinical studies" implies having e-cigarettes jump through the same hoops that medications must jump through. Are you OK with all products being removed from the market for 10 years while each product conducts animal studies, Phase I, Phase II, and Phase III clinical trials? But wait, that just won't happen because none of the companies that make or sell these products have a spare half a billion dollars sitting around. So are you OK with e-cigarettes being "regulated" totally off the market?
Aggregating across phases, we find that the out-of-pocket clinical period cost per approved new drug is US$ 282 million and the capitalized clinical period cost per approved new drug is US$ 467 million. These costs are more than four-fold higher than those we found in our previous study.
http://www.cptech.org/ip/health/econ/dimasi2003.pdf
Now these estimates were published in 2003.
The leadership at the FDA's Tobacco Program has not shown any indication whatsoever that it believes in the concept of Tobacco Harm Reduction and/or that e-cigarettes show promise. In his reply to the petition, Dr. Deyton advised e-cigarette users to participate in the Great American Smokeout.
Yup, that worked so well for us in the past.
Can you point to one thing spoken by or written by anyone who works for the FDA that gives you the idea that they plan to require
reasonable regulations? To me, reasonable regulations would be batch testing of liquid, complete and correct labeling (including poison warnings), and the option for child-proof caps.
What they should do and what they can do are two different things. There is a clause in the Tobacco Control act that states no new tobacco products can be introduced after 2007. This means that the FDA could a) claim that there were zero electronic cigarettes being sold before the cut-off, or b) select one product that was on that market then and then require a lot of proof that anything introduced after that is "substantially equivalent". If they went with Option a, all e-cigarettes would be banned. If they went with Option b, we would be left with the Ruyan R4081--an underpowered e-cig with batteries that go dead in about half a day and with tobacco flavored liquid at a maximum strength of 16 mg (1.6%).
How many of the FDA TPSAC meetings have you watched? Have you heard the questions being asked by the members of the Tobacco Products Scientific Advisory Committee? The bias of some of the members of that committee is very obvious.
So how would you suggest we make sure that regulations are actually in the best interest of the million or so former smokers who need these products to be kept available and effective, and to keep them available and effective for as many of the 45 million or so current smokers who might be persuaded to switch to something less hazardous?